Preheparin serum lipoprotein lipase mass level: the effects of age, gender, and types of hyperlipidemias

被引:63
作者
Watanabe, H
Miyashita, Y
Murano, T
Hiroh, Y
Itoh, Y
Shirai, K
机构
[1] Toho Univ, Sch Med, Sakura Hosp, Dept Clin Lab Med, Sakura, Chiba 2850841, Japan
[2] Toho Univ, Sch Med, Sakura Hosp, Dept Internal Med, Sakura, Chiba 2850841, Japan
[3] Mitsubishi Kagaku Bioclin Labs, Chiba, Japan
关键词
lipoprotein lipase; preheparin serum LPL mass; age; gender; remnants;
D O I
10.1016/S0021-9150(99)00012-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To clarify the factors regulating preheparin serum lipoprotein lipase mass (preheparin LPL mass), the correlations between preheparin LPL mass and age, gender and types of hyperlipidemias were investigated in 377 persons who underwent annual health examinations. Preheparin LPL mass level did not significantly differ in individuals from 19 to 70 years old, for both men and women. Preheparin LPL mass level correlated negatively with triglyceride (TCJ), positively with high density lipoprotein-cholesterol (HDL-C), and not at all with total cholesterol (TC) or low density lipoprotein-cholesterol (LDL-C). Preheparin LPL mass levels were apparently higher in women than in men, but when serum lipid levels were adjusted, preheparin LPL mass levels were identical. In type IV and IIb hyperlipidemia, preheparin LPL mass levels were lower than in type IIa patients and in normals. Remnant positive individuals had lower levels of preheparin LPL mass than the negative individuals. In conclusion, preheparin LPL mass levels were not affected by aging and gender, but were lower in the conditions in which TG catabolism was disturbed, indicating that preheparin LPL mass might reflect somewhat the amount of LPL working in the body. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:45 / 50
页数:6
相关论文
共 27 条
  • [1] REGULATION OF THE SYNTHESIS, PROCESSING AND TRANSLOCATION OF LIPOPROTEIN-LIPASE
    BRAUN, JEA
    SEVERSON, DL
    [J]. BIOCHEMICAL JOURNAL, 1992, 287 : 337 - 347
  • [2] BURSTEIN M, 1970, J LIPID RES, V11, P583
  • [3] ECKEL RH, 1989, NEW ENGL J MED, V320, P1060
  • [4] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [5] INTERCHANGE OF APOLIPOPROTEINS BETWEEN CHYLOMICRONS AND HIGH-DENSITY LIPOPROTEINS DURING ALIMENTARY LIPEMIA IN MAN
    HAVEL, RJ
    KANE, JP
    KASHYAP, ML
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (01) : 32 - 38
  • [6] INCREASED FREQUENCY OF LIPOPROTEIN DISORDERS SIMILAR TO TYPE-III HYPERLIPOPROTEINEMIA IN SURVIVORS OF MYOCARDIAL-INFARCTION IN JAPAN
    KAMEDA, K
    MATSUZAWA, Y
    KUBO, M
    ISHIKAWA, K
    MAEJIMA, I
    YAMAMURA, T
    YAMAMOTO, A
    TARUI, S
    [J]. ATHEROSCLEROSIS, 1984, 51 (2-3) : 241 - 249
  • [7] LIPOPROTEIN-LIPASE MASS AND ACTIVITY IN SEVERE HYPERTRIGLYCERIDEMIA
    KOBAYASHI, J
    HASHIMOTO, H
    FUKAMACHI, I
    TASHIRO, J
    SHIRAI, K
    SAITO, Y
    YOSHIDA, S
    [J]. CLINICA CHIMICA ACTA, 1993, 216 (1-2) : 113 - 123
  • [8] KRAPP A, 1995, J LIPID RES, V36, P2362
  • [9] Louis CS, 1984, LIPOPROTEIN LIPASE L, P263
  • [10] SEX-RELATED AND AGE-RELATED VARIATIONS IN THE INVITRO HEPARIN-RELEASABLE LIPOPROTEIN-LIPASE FROM MONONUCLEAR LEUKOCYTES IN BLOOD
    MAEHIRA, F
    MIYAGI, I
    EGUCHI, Y
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1042 (03) : 344 - 351